Skip to main content

BOD Australia Health Care

$0.069 0.004 (6.15%)

High

$0.07

Low

$0.07

Trades

11

Turnover

$3,477

Volume

53,435
30 June 2023 at 4:10pm
Register to track BOD and receive email alerts.
Subject
StockBot
BOD Ann: Appendix 3B - extended closing date for Entitlement Offer

StockBot
BOD Ann: Change in substantial holding

StockBot
BOD Ann: Extension of Closing Date for Entitlement Offer

StockBot
BOD Ann: Entitlement Offer Booklet

StockBot
BOD Ann: Entitlement Offer - Letter to Eligible Shareholders

StockBot
BOD Ann: Entitlement Offer - Letter to Ineligible Shareholders

StockBot
BOD Ann: Section 708A cleansing notice - Placement

StockBot
BOD Ann: Application for quotation of securities - BOD

StockBot
BOD Ann: Appendix 3B Entitlement Offer - amended issue date

StockBot
BOD Ann: Appendix 3B Entitlement Offer

StockBot
BOD Ann: Proposed issue of securities - BOD

StockBot
BOD Ann: Section 708AA(2) cleansing notice

StockBot
BOD Ann: Investor Presentation

StockBot
BOD Ann: Capital raising and transformational acquisition

StockBot
BOD Ann: Appendix 4E and full year statutory accounts

StockBot
BOD Ann: Bod to acquire Aqua Phase

StockBot
BOD Ann: Trading Halt

StockBot
BOD Ann: Bod awarded US Hemp Authority certificate for CBD extract

StockBot
BOD Ann: Quarterly activities report and Appendix 4C

StockBot
BOD Ann: CBD Schedule 3 product to be launched via SAS-B channel

StockBot
BOD Ann: Study highlights efficacy of new medicinal cannabis product

StockBot
BOD Ann: Final Director's Interest Notice

StockBot
BOD Ann: Non-Executive Chairman Transition

StockBot
BOD Ann: First patients enrolled for Schedule 3 CBD clinical trial

StockBot
BOD Ann: Quarterly Activities Report and Appendix 4C

StockBot
BOD Ann: First patients enrolled for Long COVID study

StockBot
BOD Ann: Initial Director's Interest Notice - David Baker

StockBot
BOD Ann: Final Director's Interest Notice - Simon O'Loughlin

StockBot
BOD Ann: Appointment and resignation of Non-Executive Director

StockBot
BOD Ann: Half Year Activities Report

StockBot
BOD Ann: Half Year Accounts and Appendix 4D

StockBot
BOD Ann: Novel food application accepted by UK Food Service Agency

StockBot
BOD Ann: Quarterly Activities Report and Quarterly Cash Flow Report

StockBot
BOD Ann: Ethics approval received for Schedule 3 clinical trial

StockBot
BOD Ann: Authorisation secured for UK based long covid clinical trial

StockBot
BOD Ann: Notification regarding unquoted securities - BOD

StockBot
BOD Ann: Results of Meeting

StockBot
BOD Ann: CEO presentation to AGM

StockBot
BOD Ann: Appendix 4G and Corporate Governance Statement

StockBot
BOD Ann: Annual Report to shareholders

StockBot
BOD Ann: Quarterly Activities Report and Appendix 4C

StockBot
BOD Ann: Notice of Annual General Meeting/Proxy Form

Register to track BOD and receive email alerts.